Table 2.
Mean best corrected visual acuity and central retinal thickness values at baseline and at the 3-, 6-, 12-, and 24-month follow-up for AMD and AMD/ERM groups.
| AMD group | P value | AMD/ERM group | P value | |
|---|---|---|---|---|
| Mean baseline BCVA, logMAR ± SD (range) | 0.71 ± 0.28 (0.3–1.3) |
0.73 ± 0.31 (0.3–1.3) |
||
| Mean BCVA at 3 months, logMAR ± SD (range) | 0.61 ± 0.22 (0.2–1.0) |
0.02 | 0.64 ± 0.32 (0.3–1.1) |
0.03 |
| Mean BCVA at 6 months, logMAR ± SD (range) | 0.63 ± 0.21 (0.3–1.0) |
0.11 | 0.66 ± 0.31 (0.3–1.1) |
0.13 |
| Mean BCVA at 12 months, logMAR ± SD (range) | 0.63 ± 0.22 (0.3–1.0) |
0.13 | 0.67 ± 0.28 (0.3–1.2) |
0.21 |
| Mean BCVA at 24 months, logMAR ± SD (range) | 0.66 ± 0.24 (0.3–1.0) |
0.39 | 0.70 ± 0.25 (0.3–1.3) |
0.52 |
| Mean baseline CRT, μm ± SD (range) | 315 ± 102 (275–462) |
371 ± 95 (298–519) |
||
| Mean CRT at 3 months, μm ± SD (range) | 224 ± 63 (172–284) |
<0.001 | 301 ± 86 (221–353) |
<0.001 |
| Mean CRT at 6 months, μm ± SD (range) | 257 ± 71 (178–299) |
<0.001 | 322 ± 90 (263–367) |
<0.001 |
| Mean CRT at 12 months, μm ± SD (range) | 245 ± 73 (160–312) |
<0.001 | 311 ± 67 (232–380) |
<0.001 |
| Mean CRT at 24 months, μm ± SD (range) | 225 ± 62 (153–302) |
<0.001 | 314 ± 77 (240–391) |
<0.001 |
AMD, age-related macular degeneration; ERM, epiretinal membrane; BCVA, best corrected visual acuity; CRT, central retinal thickness; SD, standard deviation.
*One-way ANOVA test for all comparisons.